{{Rsnum
|rsid=4886605
|Chromosome=15
|position=74733647
|Orientation=plus
|GMAF=0.3939
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 20.4 | 0.9
| HCB | 15.3 | 49.6 | 35.0
| JPT | 15.9 | 54.9 | 29.2
| YRI | 20.4 | 40.8 | 38.8
| ASW | 15.8 | 59.6 | 24.6
| CHB | 15.3 | 49.6 | 35.0
| CHD | 22.9 | 48.6 | 28.4
| GIH | 46.0 | 43.0 | 11.0
| LWK | 18.2 | 59.1 | 22.7
| MEX | 36.2 | 39.7 | 24.1
| MKK | 37.2 | 49.4 | 13.5
| TSI | 70.6 | 28.4 | 1.0
| HapMapRevision=28
}}{{PMID|18415690}} 577 testicular germ cell tumors cases (254 seminoma, 323 nonseminoma) and 707 controls. 

inversely associated with nonseminoma: 
*[[rs4886605]] OR = 0.75 (95% CI = 0.54-1.04) among the heterozygotes and OR = 0.37, 95% CI = 0.12-1.11 among the homozygotes with a p-value for trend = 0.02; 
*[[rs2606345]] OR = 0.69 (95% CI = 0.51-0.93) among heterozygotes and OR = 0.70 (95% CI = 0.42-1.17) among homozygotes, with a p-value for trend = 0.02.

{{PMID|19110417}} hepatocellular carcinoma in Chinese populations
*increased risk [[rs4646421]] (OR 1.30, 95% CI 1.05-1.61)
*increased risk [[rs2198843]] (OR 1.33, 95% CI 1.05-1.69)
*reduced risk [[rs4886605]] (OR 0.70. 95% CI 0.52-0.94)

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}